• Trials and Research

  Tecfidera Compared to Bafiertam in Phase 1 Study of GI Tolerability

  Posted by MS News Today Moderator on August 6, 2019 at 11:52 am

  

  The first healthy volunteer has enrolled in a single-site, randomized Phase 1 study of GI tolerabilty that compares oral Tecfidera to bioequivalent Bafiertam. Learn more about the study here.

  What do you think of this news?

  replied 6 years, 8 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply